Griffiths, C.E.M., K.A. Papp, M Song, M Miller, Y You, Y-K Shen, C Han, and A Blauvelt. “Maintenance of Response With up to 4 Years of Continuous Guselkumab Treatment: Results From the VOYAGE 1 Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S17. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/744.